HF
ANIP icon

HRT Financial’s ANI Pharmaceuticals ANIP Stock Holding History

HRT Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
16,832
-5,218
-24% -$407K ﹤0.01% 1902
2025
Q4 		$1.74M Sell
22,050
-17,996
-45% -$1.56M 0.01% 1392
2025
Q3 		$3.67M Buy
+40,046
New +$3.27M 0.01% 822
2025
Q1 		– Sell
-40,283
Closed -$2.23M – 2482
2024
Q4 		$2.23M Buy
+40,283
New +$2.31M 0.01% 692
2024
Q1 		– Sell
-28,634
Closed -$1.58M – 2268
2023
Q4 		$1.58M Buy
+28,634
New +$1.58M 0.01% 764
2023
Q2 		– Sell
-9,245
Closed -$367K – 2424
2023
Q1 		$367K Buy
+9,245
New +$390K ﹤0.01% 1591
2021
Q4 		– Sell
-8,064
Closed -$264K – 3129
2021
Q3 		$264K Buy
+8,064
New +$251K ﹤0.01% 2500

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRT Financial's ANIP Position: Q1 2026 in Review

HRT Financial reduced its ANI Pharmaceuticals (ANIP) stake by 24% in Q1 2026, selling an estimated $407K and leaving 16,832 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

HRT Financial first reported a position in ANIP in Q3 2021 and has held it in 7 quarters since. The position peaked at $3.67M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • HRT Financial held 16,832 shares of ANI Pharmaceuticals worth $1.29M as of Q1 2026.
  • HRT Financial sold 5,218 ANI Pharmaceuticals shares in Q1 2026, an estimated $407K.
  • ANI Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1902 holding.
  • HRT Financial first reported a position in ANI Pharmaceuticals in Q3 2021 and has held it in 7 quarters since.
  • HRT Financial's ANI Pharmaceuticals position peaked at $3.67M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.